Novateor Research Laboratories
35.10
0.00(0.00%)
Market Cap₹21.20 Cr
PE Ratio206.47
Company Performance:
1D0.00%
1M0.00%
6M0.00%
1Y0.00%
5Y0.00%
View Company Insightsright
More news about Novateor Research Laboratories
31May 26
Novateor reports FY26 profit with qualified audit opinion
Novateor Research Laboratories announced its audited standalone financial results for the year and half-year ended March 31, 2026, reporting a net profit of ₹10.12 lakh for the full year. Revenue from operations increased to ₹382.75 lakh from ₹277.73 lakh in the previous year. The statutory auditor, H K Shah & Co., issued a qualified opinion due to non-compliance with AS-2, AS-9, AS-15, and AS-17, specifically regarding inventory valuation, unrealized interest income under legal dispute, lack of gratuity provision, and absence of segment reporting. The board approved the results at a meeting on May 30, 2026.
 no imag found
30Apr 26
Novateor Research Laboratories Launches SmiloShine Herbafresh Toothpaste with 8 Herbs Formulation
Novateor Research Laboratories Limited announced the launch of SmiloShine Herbafresh Toothpaste with 8 herbs formulation on April 30, 2026, as part of its forward integration strategy. The oral care FMCG product will be available in 6-gram packs for hotel and travel segments and 100-gram packs for broader FMCG market penetration. The company has informed BSE Limited about this launch under SEBI Regulation 30, targeting both domestic and international markets with this herbal oral care product.
 no imag found
11Feb 26
Novateor Research Laboratories Launches SmiloShine Aligner and Denture Cleaner Foam
Novateor Research Laboratories Limited launched SmiloShine Aligner and Denture Cleaner and Whitener Foam on February 10, 2026, as announced in a BSE filing on February 11, 2026. The oral care product targets both domestic and international markets and represents a forward integration step for the cosmetic and pharmaceutical company.
 no imag found
04Nov 25
Novateor Research Laboratories Appoints New Company Secretary and Compliance Officer
Novateor Research Laboratories Limited has appointed Mrs. Pooja Bafna Rathi as its new Company Secretary cum Compliance Officer, effective November 3, 2025. Mrs. Rathi, an Associate Company Secretary with diverse qualifications including LLB and M.Com in Business Policy and Corporate Governance, will serve as a Whole Time Key Managerial Personnel. The appointment complies with Section 203 of the Companies Act, 2013, and SEBI regulations. Mrs. Rathi currently holds no shares in the company.
 no imag found
01Oct 25
Novateor Research Laboratories Seeks Shareholder Approval for Business Expansion
Novateor Research Laboratories Limited (BSE: 542771) is seeking shareholder approval to diversify into dental equipment trading and chemicals trading. The company proposes to amend its Memorandum of Association to include these new business activities. For dental equipment, Novateor plans to import, export, distribute, and deal in various dental products and act as a representative for manufacturers. In chemicals, the company aims to trade, formulate, and provide services related to various chemical products. The company held its 14th AGM on September 30 to present these amendments as a special resolution. Mr. Anil Tilakraj Arora has been appointed as a Non-Executive Independent Director for five years. The company has also closed its trading window for insiders in compliance with SEBI regulations.
 no imag found
30Sept 25
Novateor Research Laboratories Appoints Dental Expert Anil Tilakraj Arora as Independent Director
Novateor Research Laboratories Limited (BSE: 542771) has appointed Mr. Anil Tilakraj Arora as a Non-Executive Independent Director for a five-year term, effective September 3, 2025. Mr. Arora, with over 40 years of experience in dentistry, brings expertise from introducing India's largest private dental magazine, hosting major dental exhibitions, and running extensive dental workshops. The appointment, approved at the company's 14th AGM, aligns with corporate governance practices. The AGM also addressed financial statement adoption, director reappointment, and trading window closure for insiders.
 no imag found
1 Year Returns:0.00%
Industry Peers
Dabur India
376.00
(-0.12%)
Colgate Palmolive
1,797.40
(-0.61%)
Cupid
280.00
(+0.92%)
Gillette
7,307.00
(-1.06%)
Emami
363.80
(-1.90%)
Mamaearth
471.15
(-0.95%)
Bajaj Consumer Care
520.50
(-0.75%)
Anondita Medicare
1,129.55
(+0.10%)